Sergio Fazio

Professor of Medicine and Pathology

Atherosclerosis Research Unit in the Departments of Medicine and Pathology, Division of Cardiovascular Medicine at Vanderbilt University Medical Center

Read more

Articles by Sergio Fazio, Professor of Medicine and Pathology

Fibrates — The Other Life-saving Lipid Drugs

Sergio Fazio,

Citation: US Cardiology 2004;1(1):22–4

DOI:

https://doi.org/10.15420/usc.2004.1.1.22
Treating the Common Dyslipidemia in Patients with Type 2 Diabetes—The Effects of Fenofibrate on Cardiovascular Disease Risk

Sergio Fazio,

Citation: US Cardiology 2006;3(1):1–5

Fibrates — The Other Life-saving Lipid Drugs

Sergio Fazio,

Citation: US Cardiology 2004;1(1):1–6

Treating the Common Dyslipidemia in Patients with Type 2 Diabetes—Insights from FIELD on the Effects of Fenofibrate on CVD Risk

Sergio Fazio,

Citation: US Cardiology 2006;3(1):21–6

DOI:

https://doi.org/10.15420/usc.2006.3.1.21
Treating Atherogenic Dyslipidemia in Patients with Type 2 Diabetes—The Case for Using Fenofibrate

Sergio Fazio,

Citation: US Cardiology 2005;2(1):39–43

DOI:

https://doi.org/10.15420/usc.2005.2.1.39